Zoetis (ZTS) Dividends payables (2013 - 2026)
Zoetis (ZTS) posted quarterly Dividends payables of $224.0 million for Q1 2026, little changed year-over-year from $224.0 million in Q1 2025, and down 3.45% quarter-over-quarter from $232.0 million in Q4 2025.
Zoetis (ZTS) Dividends payables (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Dividends payables for 14 consecutive years, with $224.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Dividends payables changed 0.0% year-over-year to $224.0 million; the TTM figure through Mar 2026 stood at $224.0 million (changed 0.0% YoY), while the FY2025 annual figure was $232.0 million, up 3.57% from the prior year.
- Dividends payables retreated to $224.0 million in Q1 2026 per ZTS's latest filing, from $232.0 million in the prior quarter.
- Across five years, Dividends payables topped out at $232.0 million in Q4 2025 and bottomed at $153.0 million in Q1 2022.
- Historically, Dividends payables has averaged $195.8 million across 5 years, with a median of $198.0 million in 2023.
- Annual changes were most pronounced in 2022 — Dividends payables climbed 28.57% — and 2026, when it changed 0.0%.
- Zoetis' Dividends payables stood at $174.0 million in 2022, then climbed by 13.79% to $198.0 million in 2023, then increased by 13.13% to $224.0 million in 2024, then grew by 3.57% to $232.0 million in 2025, then slipped by 3.45% to $224.0 million in 2026.
- Business Quant data shows ZTS's Dividends payables at $224.0 million in Q1 2026, $232.0 million in Q4 2025, and $222.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 221.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 221.00 Mn |
| Mar 31, 2026 | 224.00 Mn |
| Dec 31, 2025 | 232.00 Mn |
| Jun 30, 2025 | 222.00 Mn |
| Mar 31, 2025 | 224.00 Mn |
| Dec 31, 2024 | 224.00 Mn |
| Jun 30, 2024 | 197.00 Mn |
| Mar 31, 2024 | 198.00 Mn |
| Dec 31, 2023 | 198.00 Mn |
| Jun 30, 2023 | 173.00 Mn |
| Mar 31, 2023 | 174.00 Mn |
| Dec 31, 2022 | 174.00 Mn |
| Jun 30, 2022 | 153.00 Mn |
| Mar 31, 2022 | 153.00 Mn |
| Dec 31, 2021 | 154.00 Mn |
| Jun 30, 2021 | 119.00 Mn |
| Mar 31, 2021 | 119.00 Mn |
| Dec 31, 2020 | 119.00 Mn |
| Jun 30, 2020 | 95.00 Mn |
| Mar 31, 2020 | 95.00 Mn |